Conference Coverage

VIDEO: Don’t discount topical therapy for psoriasis


 

AT SDEF LAS VEGAS DERMATOLOGY SEMINAR

References

LAS VEGAS– Don’t underestimate the value of topical therapy for treating psoriasis patients, Dr. Linda Stein Gold said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.

Dr. Stein Gold explained how to overcome some of the compliance issues associated with topical therapies for psoriasis, and offered her suggestions for managing side effects in an interview at the meeting.

Dr. Stein Gold disclosed relationships with multiple pharmaceutical companies including Galderma, Stiefel, Allergan, Valeant, Ranbaxy, Promius, and Actavis.

SDEF and this news organization are owned by Frontline Medical Communications.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

hsplete@frontlinemedcom.com

Recommended Reading

Biosimilars poised to make biologics more routine
MDedge Internal Medicine
VIDEO: Dr. Alan Menter discusses apremilast’s approval for psoriasis
MDedge Internal Medicine
Psoriasis severity linked to uncontrolled hypertension
MDedge Internal Medicine
In psoriasis, is pushing for PASI 90 really worthwhile?
MDedge Internal Medicine
Secukinumab showed sustained efficacy in psoriasis
MDedge Internal Medicine
FDA panel unanimously supports secukinumab approval for psoriasis
MDedge Internal Medicine
Select biologics for dose escalation in psoriasis
MDedge Internal Medicine
Psoriasiform lesions linked to anti-TNF treatment
MDedge Internal Medicine
Novel psoriasis biologic wows with jaw-dropping results
MDedge Internal Medicine
Psoriasis patients’ QOL improved with calcipotriene/betamethasone
MDedge Internal Medicine